We are buying Appen (APX) as the stock begins to recover after a tough year. Early signs that demand is returning for the artificial intelligence company is a positive.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Market Matters Monthly Video Update: Portfolio Performance for November 2025
Close
Thursday 11th September – Dow off -220pts, SPI off -20pts
Close
Webinar Recording | Will NVIDIA Ignite or End the AI Trade?
Close
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Close
Monthly Update: Portfolio performance and positioning during October
Close
MM are buying APX in the Flagship Growth Portfolio, allocating 3% around $11.77
Add To Hit List
Related Q&A
Appen Ltd (APX)
McMillan Shakespeare Ltd (MMS)
NEC and APX
Appen and Nuix
MCMILLAN SHAKESPEARE LIMITED
Appen Ltd (APX)
Thoughts on MMS?
Pullback on MMS and SIQ
Thoughts on Appen (APX) and CSR
Thoughts on mff
MMS view going forward
Sigma and Chemist Warehouse merger
Any thoughts on Meteoric Resources (MEI)?
Thoughts on MMS and SIQ share price movements
MM call to ‘Cut Losers’ like MFG, KGN, APX
Does MM prefer MMS or SIQ?
Updated view on few battered up stocks?
Appen (APX)
New CBA Hybrid + APX & CSL
Relevant suggested news and content from the site
Video
WATCH
Market Matters Monthly Video Update: Portfolio Performance for November 2025
Recorded Wednesday 10th December
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Webinar Recording | Will NVIDIA Ignite or End the AI Trade?
Recorded Thursday 20th November
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
Video
WATCH
Monthly Update: Portfolio performance and positioning during October
Recorded Thursday 6th November
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.